Magnetic resonance mammography in comparison with mammography in the discovery of multifocal, multicentric and bilateral lesions of breast cancer
Keywords:
Breast cancer, Mammography, MRM, Multifocal, Multi-centric, BilateralAbstract
Background: Breast cancer is one of the health system problems and important diseases that is rising in developing and advanced countries.
Objective: This study aimed to determine the difference of Magnetic Resonance Mammography (MRM) findings versus mammography in detecting multifocal, multi-centric and malignant bilateral lesions in patients with known breast cancer in Tehran.
Methods: This cross-sectional study was conducted in Iran and Tehran among breast cancer patients between January 2015 and February 2016. Patients were included in the study prior to surgery, at the request of a surgeon with the aim of detecting multifocal, multi-centric and bilateral lesions. Demographic information was also collected from patients. The results for quantitative variables were expressed as mean and standard deviations, and for qualitative variables, were expressed as relative and absolute frequency. Chi-square test was used to compare the two methods. SPSS Ver.24 (IBM) software was used to analyze the data.
Results: Thirty-nine patients were enrolled in the study. The mean age of patients in this study was 48.46±6.836. In mammography, 13 (33.3%) had Composition C and 26 (66.7%) had Composition D according to the type of Composition. In total, 25 patients (89.3%) had one lesion and 3 patients (10.7%) had more than two lesions. In MRM, all lesions observed were mass (54 masses). The number of lesions found in MRM was 27 patients with one lesion (58.9%), 6 patients with two lesions (20.5%) and 5 patients with three lesions (20.6%). MRM detected more lesions compared to mammography (p<0.0001). The value of Chi-square test with a degree of freedom and error level of 0.05 was 3.71 and p<0.0001 that showed a significant relationship between the number of MRM findings in comparison with mammography.
Conclusion: The results of our study showed that two or more lesions and bilateral lesions in MRM were more than mammography in women with B Breast Composition C, D; the findings showed that MRM has a better ability to detect breast masses, and can affect the patient's surgical procedure.
References
Shaukat U, Ismail M, Mehmood N. Epidemiology, major risk factors and genetic predisposition for breast
cancer in the Pakistani population. Asian Pac J Cancer Prev. 2013; 14(10): 5625-9. doi:
7314/APJCP.2013.14.10.5625. PMID: 24289553.
Elgaili EM, Abuidriss D, Rahman M, Michalek AM, Mohammed SI. Breast cancer burden in central
Sudan. Int J Womens Health. 2010; 9(2): 77-82. PMID: 21072300, PMCID: PMC2971742.
Lin CH, Chuang PY, Chiang CJ, Lu YS, Cheng AL, Kuo WH, et al. Distinct clinicopathological features
and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer
registry-based study. Oncologist. 2014; 19(6): 583-91. doi: 10.1634/theoncologist.2014-0047. PMID:
, PMCID: PMC4041679.
Haghighi F, Mohammadifard M, Naseh G, Hashem K, Saadatjoo SA. Prevalence of breast cancer among
women over 30 years in Birjand between 2009 and 2010. J Birjand Univ Med Sci. 2013; 20(1): 68-76.
World Health Organization. Cancer country profiles 2014. 2014. Available from:
http://www.who.int/cancer/country-profiles/en/.
Jazayeri SB, Saadat S, Ramezani R, Kaviani A. Incidence of primary breast cancer in Iran: Ten-year
national cancer registry data report. Cancer Epidemiol. 2015; 39(4): 519-27. doi:
1016/j.canep.2015.04.016. PMID: 26070507.
Chuang SC, Wu GJ, Lu YS, Lin CH, Hsiung CA. Associations between Medical Conditions and Breast
Cancer Risk in Asians: A Nationwide Population-Based Study in Taiwan. PLoS One. 2015; 10(11):
e0143410. doi: 10.1371/journal.pone.0143410. PMID: 26605792, PMCID: PMC4659594.
World Health Organization. Breast cancer: prevention and control 2017. Available from:
http://www.who.int/cancer/detection/breastcancer/en/.
Maurice A, Evans DG, Affen J, Greenhalgh R, Duffy SW, Howell A. Surveillance of women at increased
risk of breast cancer using mammography and clinical breast examination: Further evidence of benefit. Int J
Cancer. 2012; 131(2): 417-25. doi: 10.1002/ijc.26394. PMID: 21898384.
Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, et al. A systematic review of the effectiveness
of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young
women at high risk of breast cancer. Eur J Cancer. 2007; 43(13): 1905-17. doi: 10.1016/j.ejca.2007.06.007.
PMID: 17681781.
King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA. Background parenchymal
enhancement at breast MR imaging and breast cancer risk. Radiology. 2011; 260(1): 50-60. doi:
1148/radiol.11102156. PMID: 21493794.
Yang SN, Li FJ, Liao YH, Chen YS, Shen WC, Huang TC. Identification of Breast Cancer Using
Integrated Information from MRI and Mammography. PLoS One. 2015; 10(6): e0128404. doi:
1371/journal.pone.0128404. PMID: 26056841, PMCID: PMC4461246.
Saadatmand S, Rutgers EJ, Tollenaar RA, Zonderland HM, Ausems MG, Keymeulen KB, et al. Breast
density as indicator for the use of mammography or MRI to screen women with familial risk for breast
cancer (FaMRIsc): a multicentre randomized controlled trial. BMC Cancer. 2012; 12: 440. doi:
1186/1471-2407-12-440. PMID: 23031619, PMCID: PMC3488502.
Shaikh T, Tam TY, Li T, Hayes SB, Goldstein L, Bleicher R, et al. Multifocal and multicentric breast
cancer is associated with increased local recurrence regardless of surgery type. Breast J. 2015; 21(2): 121- 6. doi: 10.1111/tbj.12366. PMID: 25597248.
Zhou M, Tang Z, Li J, Fan J, Pang Y, Yang H, et al. Clinical and Pathologic Features of Multifocal and
Multicentric Breast Cancer in Chinese Women: A Retrospective Cohort Study. J Breast Cancer. 2013;
(1): 77-83. doi: 10.4048/jbc.2013.16.1.77. PMID: 23593086, PMCID: PMC3625774.
Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for Breast Cancer. JAMA. 2005; 293(10):
-56. doi: 10.1001/jama.293.10.1245. PMID: 15755947, PMCID: PMC3149836.
Riedl CC, Luft N, Bernhart C, Weber M, Bernathova M, Tea MK, et al. Triple-modality screening trial for
familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of
mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol.
; 33(10): 1128-35. doi: 10.1200/JCO.2014.56.8626. PMID: 25713430, PMCID: PMC5526626.
Enayatrad M, Amoori N, Salehiniya H. Epidemiology and Trends in Breast Cancer Mortality in Iran. Iran J
Public Health. 2015; 44(3): 430–1.
Brooke HL, Ringbäck Weitoft G, Talbäck M, Feychting M, Ljung R. Adult children's socioeconomic
resources and mothers' survival after a breast cancer diagnosis: a Swedish population-based cohort study.
BMJ Open. 2017; 7(3): e014968.
Pediconi F, Catalano C, Roselli A, Dominelli V, Cagioli S, Karatasiou A, et al. The challenge of imaging
dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative
study with x-ray mammography and whole-breast ultrasound. Invest Radiol. 2009; 44(7): 412-21. doi:
1097/RLI.0b013e3181a53654. PMID: 19448554.
Adrada B, Arribas E, Gilcrease M, Yang WT. Invasive micropapillary carcinoma of the breast:
mammographic, sonographic, and MRI features. AJR Am J Roentgenol. 2009; 193(1): W58-63. doi:
2214/AJR.08.1537. PMID: 19542384.
Saha S, Sirop S, Korant A, Kanaan M, Shekher R, Strahle D, et al. Nodal positivity in breast cancer
correlated with the number of lesions detected by magnetic resonance imaging versus mammogram. Am J
Surg. 2011; 201(3): 390-4. doi: 10.1016/j.amjsurg.2010.11.006. PMID: 21367385.
Morrow M, Waters J, Morris E. MRI for breast cancer screening, diagnosis, and treatment. Lancet. 2011;
(9805): 1804-11. doi: 10.1016/S0140-6736(11)61350-0. PMID: 22098853.
Boetes C, Veltman J, van Die L, Bult P, Wobbes T, Barentsz JO. The role of MRI in invasive lobular
carcinoma. Breast Cancer Res Treat. 2004; 86(1): 31-7. doi: 10.1023/B:BREA.0000032921.10481.dc.
PMID: 15218359.
Lehman CD, Smith RA. The role of MRI in breast cancer screening. J Natl Compr Canc Netw. 2009;
(10): 1109-15. doi: 10.6004/jnccn.2009.0072. PMID: 19930977.
Ojeda-Fournier H, Comstock CE. MRI for breast cancer: Current indications. Indian J Radiol Imaging.
; 19(2): 161-9. doi: 10.4103/0971-3026.48431. PMID: 19881077, PMCID: PMC2765174.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
